24/09/2026
BLIND SPOT: Hundreds of patients are suing the makers of Ozempic, Wegovy and other GLP-1 drugs, alleging the medications caused a rare "eye stroke" linked to permanent vision loss.
The condition, called NAION, cuts blood flow to the optic nerve with no warning and no treatment. A 2024 Harvard study found semaglutide users with type 2 diabetes had roughly four times the relative risk of developing it.
Novo Nordisk called the lawsuits meritless, while the FDA says it is still reviewing the evidence and has not issued a safety warning.
Full story here ⬇️ https://www.foxnews.com/health/popular-weight-loss-drugs-face-lawsuits-rare-eye-stroke-linked-vision-loss
